Trial Profile
Proof-of-concept trial of FX007 for the treatment of musculoskeletal pain
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 07 May 2015
Price :
$35
*
At a glance
- Drugs FX 007 (Primary)
- Indications Musculoskeletal pain
- Focus Adverse reactions
- 07 May 2015 New trial record